Hepatitis B Virus Precore and Core Gene Mutations in Chronic Hepatitis B and Hepatocellular Carcinoma Patients
Yumei Wen
DOI: https://doi.org/10.1111/j.1365-2796.1993.tb00775.x
1993-01-01
Journal of Internal Medicine
Abstract:Journal of Internal MedicineVolume 234, Issue 5 p. 441-445 Free Access Hepatitis B virus precore and core gene mutations in chronic hepatitis B and hepatocellular carcinoma patients Y.-M. WEN MD, Corresponding Author Y.-M. WEN MD Department of Molecular Virology, Shanghai Medical University, Shanghai, People's Republic of ChinaDepartment of Molecular Virology, Shanghai Medical University, Shanghai 200032, People's Republic of China.Search for more papers by this author Y.-M. WEN MD, Corresponding Author Y.-M. WEN MD Department of Molecular Virology, Shanghai Medical University, Shanghai, People's Republic of ChinaDepartment of Molecular Virology, Shanghai Medical University, Shanghai 200032, People's Republic of China.Search for more papers by this author First published: November 1993 https://doi.org/10.1111/j.1365-2796.1993.tb00775.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Blumberg BS, Gerstley JS, Hungerford DA, London WT, Setnick AI. A serum antigen (Australia antigen) in Down's syndrome leukemia and hepatitis. Ann Intern Med 1967; 66: 924– 31. 2 Howard CR. The biology of hepadnaviruses. J Gen Virol 1986; 67; 1215– 35. 3 Twu JS, Wu J., Robinson WS. Hepatitis B virus X gene product expressed in E. Coli can activate transcription regulated by the HIV-1 LTR. In: FB Hollinger, SM Lemon, H. Margolis, eds. Viral Hepatitis and Liver Diseases. Baltimore; Williams & Wilkins, 1991; 182– 6. 4 Ganem D., Varmus HE. The molecular biology of the hepatitis B virus. Ann Rev Biochem 1987; 56: 651– 94. 5 Garcia PD, Ou J-H, Rutter WJ, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988; 106: 1093– 104. 6 Magnius L., Espmark J. Specifities in Australian antigen positive sera distinct from the Le Bouvier determinant. J Immunol 1972; 109: 1017– 21. 7 Schlicht HJ, Schaller H. The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol 1989; 63: 5399– 404. 8 Chang C., Enders G., Sprengel R., Peters N., Varmus HE, Ganem D. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol 1987; 61: 3322– 5. 9 Junker-Niepmann M., Bartenschlager R., Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 1990; 9: 3389– 96. 10 Hirsch RC, Loeb DD, Pollock JR, Ganem D. Cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J Virol 1991; 65: 3309– 16. 11 Petit MA, Pillot J. HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells. J Virol 1985; 53: 543– 51. 12 Milich DR, McLachlan A. HBcAg can function both as a T-cell-dependent and a T-cell-independent antigen: HBcAg and HBeAg are cross-reactive at the T cell level. In: AJ Zuckerman, ed. Viral Hepatitis and Liver Diseases. New York: Alan R Liss. 1988; 645– 9. 13 Iwarson S., Tabor E., Snoy P., Gerety RE. Protection against hepatitis B infection by immunization with hepatitis core antigen. Gastroenterology 1985; 88: 763– 7. 14 Salfeld J., Pfaff E., Noah M., Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 1989; 63: 798– 828. 15 Ferrari C., Penna A., Giuuberti T., Tong MJ, Ribera E., Fiaccadori F., Chisari FV. Intrahepatic nucleocapsid antigen specific T cells in chronic active hepatitis B. J Immunol 1987; 139: 2050– 58. 16 Penna A., Chisari FV, Bertoletti A., Missale G., Fowler P., Giuberti T., Ficcadori F., Ferrari C. Cytotoxic T Lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565– 70. 17 Bruss V., Gerlich W. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology 1988; 163: 268– 75. 18 Okamoto H., Imai M., Kamatami, Nakamura T., Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jap J Exp Med 1987; 57: 231– 6. 19 Carman WF, Jacyna MR, Hadziyannis S., Karayiannis P., McGarvey MJ, Makris A., Thomas HC. Mutation preventing formation of heptatitis e antigen in patients with chronic hepatitis B infection. Lancet 1989; ii: 588– 91. 20 Tong SP, Diot C., Gripa P., Li JS, Vitvitski L., Trepo C., Guguen-Guillouzo C. In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal Pre-C region. Virology 1991; 181: 733– 7. 21 Liang TJ, Hasegawa K., Rimon N., Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. New Eng J Med 1991; 324: 1705– 9. 22 Wen YM. Study on the mechanisms of chronicity of hepatitis B infection. Chinese Med J 1992; 105: 183– 8. 23 Raimondo G., Schneider R., Stemler M., Smedile V., Rodino G., Will H. A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis. Virology 1990; 191: 64– 8. 24 Wei Q., Zhang Q., Wen YM. Analysis of hepatitis B virus precore region in Chinese hepatitis B patients. Chinese J Virol (in press). 25 Carman WF, Ferrao M., Lok ASF, Ma OCK, Lai CL, Thomas HC. Precore sequence variation in Chinese isolates of Hepatitis B virus. J Inf Dis 1992; 165: 127– 33. 26 Bhat RA, Ulrich PL, Vyas GN. Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology 1990; 11: 271– 6. 27 Santantonio T., Jung MC, Miska S., Pastore G., Pape GR, Will H. Prevalence and type of Pre-C HBV mutants in anti-HBe-positive carriers with chronic liver disease in a highly endemic area. Virology 1991; 183: 840– 44. 28 Brunetto MR, Giarin MM, Oliveri F., Chiaberge E., Baldi M., Alfarano A., Serra A., Saracco G., Verme G., Will H., Bonino F. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 1991; 88: 4186– 90. 29 Okamoto H., Yotsumoto S., Akahane Y., Yamada T., Miyazaka Y., Sugai Y., Ysuda F., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B virus with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1278– 303. 30 Wen YM, Liu HJ, Chen HZ, Huang YX, Hu DC, Duan SC, Wu XH, Xu HF. Studies on intrahepatic hepatitis B virus DNA in 98 viral hepatitis B patients. Chinese Med J 1986; 99: 861– 5. 31 Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology 1992; 15: 144– 8. 32 Hasgawa K., Juang J., Wands JR, Obata H., Liang TJ. Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan. Virology 1991; 185: 460– 63. 33 Fugan EA, Smith PM, Davison F., William R. Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males. Lancet 1986; ii: 538– 40. 34 Chen ZP, Wen YM, Gu JR, Fan DF, Chen YQ, Yen GB. Detection of hepatitis B virus C gene variation in hepatocellular carcinoma. Chinese J Virol 1990; 6: 192– 5. 35 Kaneko S., Miller R. Heterogeneity of the core sequence in a patient chronically infected with the hepatitis B virus. J Inf Dis 1989; 160: 903– 4. 36 Trauy A., Kramsdorf D., Capel F. Emergence and take over by hepatitis B virus with rearrangements in the PreS/S and PreC/C genome during chronic HBV infection. J Virol 1991; 65: 3566– 74. 37 Wei Q., Wen YM, He LF, Li XP, Yu CI. The core gene of an HBsAg positive but anti-core antibody negative serum. Chinese J Virol 1992; 8: 91– 3. 38 Ehata T., Omata M., Yokosuka O., Hosoda K., Ohto M. Variations in codon 84–101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992; 89: 332– 8. 39 Carman WF, McIntyre G., Hadzinyannis S., Alberti A., Fattovich G., Thomas HC. Mutation of HBcAg after loss of HBeAg. J Hepatol 1992; 16: 525. 40 Carman W., Thomas H., Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; ii: 349– 53. Volume234, Issue5November 1993Pages 441-445 ReferencesRelatedInformation